Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)

See Plans and Pricing

« Back to Dashboard

Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)

Docket   Start Trial Date Filed 2015-08-24
Court District Court, E.D. Texas Date Terminated 2017-10-16
Cause 35:271 Patent Infringement Assigned To William C. Bryson
Jury Demand Both Referred To
Patents 4,839,342; 5,474,979; 8,501,174; 8,629,111; 8,633,162; 8,642,556; 8,648,048; 8,685,930; 9,248,191
Attorneys A Martina Tyreus Hufnal; Albert A Carrion , Jr.; Alina L Litoshyk; Allen Franklin Gardner; Andrea Leigh Fair; Andrew M Alul; Anna Grace Phillips; Azadeh Kokabi; Benjamin M Cappel; Brian P Murray; Byron L Pickard; Charles B Klein; Christina E Dashe; Christopher L Evans; Claire Abernathy Henry; Corinne Elisabeth Atton; Dallas William Tharpe; Deanna Jean Reichel; Deanne M Mazzochi; Deron R Dacus; Donald J Mizerk; Douglas H Carsten; Earl Glenn Thames , Jr; Eric Hugh Findlay; George Chih-lun Yu; Herbert A Yarbrough , III; Jack Wesley Hill; Jacqueline Altman; Jason Craig Hamilton; Jennifer Parker Ainsworth; John Christopher Rozendaal; John D Polivick; John K Hsu; John Wesley Samples; Jonathan Elliot Singer; Joseph Anthony Herriges; Joseph E Cwik; Juanita Rose Brooks; Katherine Reardon; Kelly Allenspach Del Dotto; Kevin Burke; Louis Brady Paddock; Mark Boland; Matthew B. Mock; Melissa Richards Smith; Michael Dzwonczyk; Michael E Joffre; Michael J Kane; Michael Wayne Shore; Miles J Sweet; Nellie J Amjadi; Patrick N Abbott; Paul J Molino; Pauline M. Pelletier; Peter Aaron Kerr; Peter J Curtin; Philip D Segrest , Jr.; R Wilson Powers , III; Robert M Oakes; Sailesh Patel; Shannon Marie Dacus; Shashank Upadhye; Shilpa Coorg; Stephen R Smerek; Susan E Morrison; Susan M Coletti; Thomas A Rammer , II; Thomas Hart Watkins; Thomas John Ward , Jr; Walter Wayne Lackey , Jr.; Wendy L Devine; William A Rakoczy; William Ellsworth Davis , III; William F Ward; William H Milliken
Firms Allen Gardner Law, PLLC; Amin Talati and Upadhye LLC; Findlay Craft PC; Fish & Richardson - Minneapolis; Fish & Richardson - New York; Fish & Richardson - San Diego; Fish & Richardson PC - Washington DC; Fitzpatrick Cella Harper & Scinto - New York; Gillam and Smith LLP; Husch Blackwell LLP Austin; Husch Blackwell LLP Chicago; Kellogg Huber Hansen Todd Evans & Figel PLLC; Nix Patterson & Roach LLP - Texarkana; Ogletree Deakins Nash Smoak & Stewart PC - San Antonio; Potter Minton, a Professional Corporation; Rakoczy Molino Mazzochi Siwik; Schiff Hardin LLP DC; Schiff Hardin LLP San Francisco; Schiff Hardin LLP-Chicago; Shore Chan DePumpo LLP; Sterne Kessler Goldstein & Fox PLLC - Washington; Sterne, Kessler, Goldstein & Fox Pllc; Sughrue Mion PLLC; Sughrue Mion PLLC DC; Taft Stettinius & Hollister, LLP - Chicago; The Dacus Firm, PC; The Davis Firm, PC Longview; Ward, Smith & Hill, PLLC; Wilson Sonsini Goodrich & Rosati - Austin; Wilson Sonsini Goodrich & Rosati - San Diego; Winston & Strawn - L.A.; Winston and Strawn LLP (DC); Yarbrough Wilcox, PLLC
Link to Docket External link to docket
Small Molecule Drugs cited in Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-08-24 1 Exhibit 4 - U.S. Patent No. 8,648,048 U.S. Patent No. 8,629,111, # 3 Exhibit 2 - U.S. Patent No. 8,633,162, # 4 Exhibit 3 - U.S. Patent No. …8,642,556, # 5 Exhibit 4 - U.S. Patent No. 8,648,048, # 6 Exhibit 5 - U.S. Patent No. 8,685,930)(Hill, Jack)…2015 16 October 2017 2:15-cv-01455 830 Patent Both District Court, E.D. Texas External link to document
2016-04-19 130 several patents relating to RESTASIS— United States Patent Numbers 8,629,111 (“the ’111 patent”), 8,633,162…,162 (“the ’162 patent”), 8,642,556 (“the ’556 patent”), 8,648,048 (“the ’048 patent”), 8,685,930 (“the…“the ’930 patent”), and 9,248,191 (“the ’191 patent”). Those patents are listed in the “Orange Book,” …’930 patents. Allergan later amended its complaint to include the ’191 patent after that patent issued… I. BACKGROUND This patent infringement action arises from Abbreviated New External link to document
2016-08-05 165 Famy Care Limited The asserted patents U.S. Patent 8,629,111 (ECF No. 155-1); …eye . . . .” See, e.g., ’162 patent, cl. 1; ’048 patent, cl. 1; ’191 patent, cl. 1. Applying the adverb… U.S. Patent 8,633,162 (ECF No. 155-2); U.S. Patent 8,642,556 (ECF… U.S. Patent 8,648,048 (ECF No. 155-4); U.S. Patent 8,685,930 (ECF…prosecution history, the patents-in-suit are not novel or innovative. Rather, the patents—which are all directed External link to document
2016-12-13 214 effective in treating dry eye. See U.S. Patent No. 4,839,342 to Kaswan. By the mid-1990s, it was known…See ’162 patent, claim 14; ’556 patent claims 1, 13-15; ’048 patent, claims 13-16; ’191 patent, claims…terms of the six patents at issue in this case, U.S. Patent Nos. 8,629,111 (“the ’111 patent”); 8,633,1628,633,162 (“the ’162 patent”); 8,642,556 (“the ’556 patent”); 8,648,048 (“the ’048 patent”); 8,685,930 (“the…the ’162 patent; claims 1, 11, and 13 of the ’556 patent; and claims 1 and 17 of the ’191 patent. The term External link to document
2017-01-12 250 of the applications as obvious over U.S. Patent No. 5,474,979 to Ding. In response to the examiner…defrauded the U.S. Patent and Trademark Office in order to obtain allowance of the patents in suit.” Teva… U.S. Patent No. 8,685,930. Two years later, the PTO issued the last of the six related patents in suit…procedural question not specific to patent law or bearing on substantive patent law issues, so the law of the…argues that the issuance of the sixth patent in suit, U.S. Patent No. 9,248,191, was the result of the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.